Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ACE inhibition in cardiovascular disease.

× No keyword cloud information.

9 in total

Review 1. Angiotensin I-converting enzyme: genotype and disease associations.

Authors: D Crisan; J Carr
Journal: J Mol Diagn Date: 2000-08 Impact factor: 5.568

Review 2. [New antiarrhythmic drugs for therapy of atrial fibrillation: II. Non-ion channel blockers].

Authors: M Hammwöhner; A D'Alessandro; D Dobrev; P Kirchhof; A Goette
Journal: Herzschrittmacherther Elektrophysiol Date: 2006-06

Review 3. Angiotensin antagonism in coronary artery disease: results after coronary revascularisation.

Authors: Flavio Ribichini; Valeria Ferrero; Andrea Rognoni; Giovanni Vacca; Corrado Vassanelli
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 4. The use of ACE inhibitors on diabetic patients without renal disease.

Authors: Dmitri Kirpichnikov; Nathaniel Winer; James R Sowers
Journal: Curr Diab Rep Date: 2002-02 Impact factor: 4.810

5. Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.

Authors: Christos Kalofoutis; Christina Piperi; Anastasios Kalofoutis; Fred Harris; David Phoenix; Jaipaul Singh
Journal: Exp Clin Cardiol Date: 2007

6. Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism.

Authors: Denis J Glenn; Dolkun Rahmutula; Minobu Nishimoto; Faquan Liang; David G Gardner
Journal: Cardiovasc Res Date: 2009-06-22 Impact factor: 10.787

ACE inhibition in cardiovascular disease.

Review 1. Angiotensin I-converting enzyme: genotype and disease associations.

Review 2. [New antiarrhythmic drugs for therapy of atrial fibrillation: II. Non-ion channel blockers].

Review 3. Angiotensin antagonism in coronary artery disease: results after coronary revascularisation.

Review 4. The use of ACE inhibitors on diabetic patients without renal disease.

5. Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.

6. Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism.

7. Angiotensin-converting enzyme inhibitors will help in improving stroke outcome if given immediately after stroke.

8. Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity.

9. Implications of recent hypertension trials for the generalist physician: whom do we treat, and how?